Jump to content
RemedySpot.com

Abatacept: New fusion protein for potential treatment of various immunological disorders

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 04

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Technology evaluation: abatacept, Bristol-Myers Squibb.

Curr Opin Mol Ther. 2004 Jun;6(3):318-30.

Dumont FJ.

Bristol-Myers Squibb is developing the fusion protein abatacept for the

potential treatment of various immunological disorders, including

rheumatoid arthritis, multiple sclerosis and systemic lupus

erythematosus. Abatacept is undergoing phase III clinical trials.

Medor Consulting, 421 Dogwood Avenue, Egg Harbor Twp, NJ 08234, USA.

francisj_dumont@...

PMID: 15264435 [PubMed - in process]

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...